Scott A Fiore

Title: Spotlight on Inventor Scott A. Fiore

Introduction: Scott A. Fiore is a noted inventor based in Westminster, Colorado, recognized for his contributions to the pharmaceutical industry. With a focus on enhancing drug formulation processes, he has demonstrated innovative thinking in the area of spheronization.

Latest Patents: Fiore holds a patent for a "Microcrystalline cellulose spheronization composition." This inventive particulate co-processed formulation combines microcrystalline cellulose with hydrocolloids in a specific weight ratio ranging from about 99:1 to 70:30. The unique composition serves as a spheronizing agent, enabling the production of spheroids that exhibit uniform size and sphericity, alongside high drug loadings. The method involves drying a slurry of microcrystalline cellulose in an aqueous hydrocolloid solution, with methylcellulose being the preferred hydrocolloid.

Career Highlights: Scott A. Fiore is associated with FMC Corporation, a key player in the chemical industry known for its innovative solutions. His work within the company showcases his commitment to advancing drug delivery systems and formulations.

Collaborations: Throughout his career, Fiore has collaborated with notable colleagues, including David F. Erkoboni and Thomas A. Wheatley. These partnerships have likely contributed to the innovative approaches and successful outcomes in their projects.

Conclusion: As a dedicated inventor, Scott A. Fiore continues to make strides in the field of pharmaceutical formulations. His patented microcrystalline cellulose spheronization composition reflects his ability to combine scientific knowledge with inventive skill, ultimately benefiting drug delivery and patient care.